Publications by authors named "Dali Yan"

Claim this Profile
H
Harnessing single-cell and multi-omics insights: STING pathway-based predictive signature for immunotherapy response in lung adenocarcinoma.
Yang Ding, Dingli Wang, Dali Yan, Jun Fan, Zongli Ding

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Harnessing single-cell and multi-omics insights: STING pathway-based predictive signature for immunotherapy response in lung adenocarcinoma.
Yang Ding, Dingli Wang, Dali Yan, Jun Fan, Zongli Ding

Front Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unravelling tumour cell diversity and prognostic signatures in cutaneous melanoma through machine learning analysis.
Wenhao Cheng, Ping Ni, Hao Wu, Xiaye Miao, Xiaodong Zhao, Dali Yan

J Cell Mol Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA m5C methylation orchestrates BLCA progression via macrophage reprogramming.
Dali Yan, Yongsong Xie, Liyuan Huang, Yi Zhang, Runhuan Gu

J Cell Mol Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approaching high-performance of ordered structure SbTe film via unique angular intraplanar grain boundaries.
Ming Tan, Liyu Hao, Hui Li, Cong Li, Xiaobiao Liu, Dali Yan, Tie Yang

Sci Rep· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tilt-structure and high-performance of hierarchical BiSbTe nanopillar arrays.
Ming Tan, Yanming Hao, Yuan Deng, Dali Yan, Zehua Wu

Sci Rep· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Xiaobing Qin, Shaorong Yu, Leilei Zhou, Meiqi Shi, Yong Hu, Dali Yan

Int J Nanomedicine· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of nab-paclitaxel in metastatic breast cancer: a meta-analysis of randomized clinical trials.
Yun Liu, Guoxin Ye, Dali Yan, Lei Zhang, Fan Fan

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
Lei Zhang, Da-Li Yan, Fan Yang, Dan-Dan Wang, Xiu Chen

Oncotarget· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-138: A promising therapeutic target for cancer.
Huan-Huan Sha, Dan-Dan Wang, Dan Chen, Si-Wen Liu, Zhen Wang, Da-Li Yan

Tumour Biol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin.
Yong Hu, Jialan Zang, Xiaobing Qin, Dali Yan, Haixia Cao

Onco Targets Ther· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation.
Yong Hu, Xiaobing Qin, Dali Yan, Haixia Cao, Leilei Zhou

Tumour Biol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimaeric antigen receptor T-cell therapy for tumour immunotherapy.
Huan-Huan Sha, Dan-Dan Wang, Da-Li Yan, Yong Hu, Su-Jin Yang

Biosci Rep· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.
Yong Hu, Jialan Zang, Haixia Cao, Ying Wu, Dali Yan

Oncotarget· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer.
Jialan Zang, Yong Hu, Xiaoyue Xu, Jie Ni, Dali Yan

Onco Targets Ther· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer.
Long-Ji Luo, Fan Yang, Jia-Ji Ding, Da-Li Yan, Dan-Dan Wang, Su-Jin Yang

Gene· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver X receptor as a drug target for the treatment of breast cancer.
Ying Wu, Dan-Dan Yu, Da-Li Yan, Yong Hu, Dan Chen

Anticancer Drugs· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide profiling of long non-coding RNA expression patterns in the EGFR-TKI resistance of lung adenocarcinoma by microarray.
Ying Wu, Dan-Dan Yu, Yong Hu, Dali Yan, Xiu Chen

Oncol Rep· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WITHDRAWN: The long non-coding RNA, LINC00635-001, sensitizes EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activation.
Ying Wu, Dan-Dan Yu, Yong Hu, Da-Li Yan, Xiu Chen

Biochem Biophys Res Commun· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis